Gene knockdown with lentiviral vector-mediated intrathecal RNA interference of protein kinase C gamma reverses chronic morphine tolerance in rats
Gene knockdown with lentiviral vector-mediated intrathecal RNA interference of protein kinase C gamma reverses chronic morphine tolerance in rats
复制标题
慢病毒载体介导的蛋白激酶 C γ 鞘内 RNA 干扰基因敲除可逆转大鼠慢性吗啡耐受
DOI:
10.1002/jgm.1514
复制
发表时间:
2010-11-01
影响因子:
3.5
通讯作者:
Guo, Qulian
中科院分区:
文献类型:
--
作者:
Song, Zongbin;Zou, Wangyuan;Guo, Qulian
Background Although morphine is a widely used opioid analgesic, morphine tolerance (MT) has limited the use of the drug because it creates the necessity for high doses. Protein kinase C (PKC), especially the PKC gamma isoform, is considered to play a key role in the development of MT. Because RNA interference provides a powerful method for the investigation of gene function, and lentiviral delivery systems have been approved for human use, this present study examined rats tolerant to morphine to determine whether an intrathecal injection of a lentiviral vector of PKC gamma short hairpin RNA (LV-shPKC gamma) down-regulated the expression of the PKC gamma gene and reversed MT.Methods MT was induced by intrathecal morphine (10 mu g b.i.d.) for six consecutive days. A lentiviral-mediated short hairpin RNA (shRNA) system was synthesized to deliver the PKC gamma shRNAs to the spinal cord of the rats with MT. Mechanical and thermal paw withdrawal threshold were assessed to determine the analgesic effects of morphine. Expression of PKC gamma mRNA and protein was determined by reverse transcriptase-polymerase chain reaction and western blotting analysis, respectively.Results The chronic administration of morphine induced a stabilized analgesic tolerance. A single injection of LV-shPKC gamma significantly reversed morphine antinociceptive tolerance. Compared to the control group, PKC gamma mRNA and protein levels were dramatically down-regulated in the LV-shPKC gamma group.Conclusions A single injection of LV-shPKC gamma reversed MT by reducing the expression of PKC gamma in the spinal cord. These findings indicate that the use of LV-shPKC gamma might be a potential strategy for therapy in MT. Copyright (C) 2010 John Wiley & Sons, Ltd.